Statement Of Changes In Equity [Abstract]

Xbrane Biopharma - Filing #689992

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
551,000 SEK
160 502 SEK
159 951 SEK
SEK
SEK
360 552 SEK
637,000 SEK
SEK
361 189 SEK
SEK
Share issue related cost
13 350 SEK
13 350 SEK
24 231 SEK
24 231 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.